...
首页> 外文期刊>Journal of Medical Genetics >Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes.
【24h】

Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes.

机译:良性疾病的放射治疗后恶变和新发原发性肿瘤:某些易发肿瘤综合症的重大风险。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In recent years the use of radiation treatment for benign tumours has increased with the advent of stereotactic delivery and, in particular, single high dose gamma knife therapy. This has been particularly true for benign CNS (central nervous system) tumours such as vestibular schwannoma, meningioma, pituitary adenoma, and haemangioblastoma. While short term follow up in patients with isolated tumours suggests this treatment is safe, there are particular concerns regarding its use in childhood and in tumour predisposing syndromes. We have reviewed the use of radiation treatment in these contexts with particular regard to malignant transformation and new tumour induction. This review indicates that much more caution is warranted regarding the use of radiation treatment for benign tumours in childhood and in tumour prone conditions such as the neurofibromatoses.
机译:近年来,随着立体定向递送的出现,尤其是单次高剂量伽玛刀疗法的出现,放射治疗对良性肿瘤的使用有所增加。对于良性中枢神经系统(中枢神经系统)肿瘤尤其如此,例如前庭神经鞘瘤,脑膜瘤,垂体腺瘤和血管母细胞瘤。虽然对患有孤立肿瘤的患者进行短期随访表明这种治疗是安全的,但特别需要关注其在儿童期和肿瘤易感综合症中的使用。我们已经审查了在这些情况下放射治疗的使用,特别是关于恶性转化和新肿瘤的诱导。这篇评论表明,对于在儿童期和肿瘤易发性疾病(例如神经纤维瘤)中对良性肿瘤使用放射治疗,需要更加谨慎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号